AstraZeneca vaccine 79% effective against symptomatic Covid, company says
AstraZeneca vaccine 79% effective against symptomatic Covid, company says
AstraZeneca’s Covid-19 vaccine showed 79% efficacy against symptomatic disease and 100% efficacy against severe disease and hospitalization in a new, US-based clinical trial, the company said Monday.
Published at Mon, 22 Mar 2021 09:45:41 GMT
